Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine.

× No keyword cloud information.

42 in total

Review 1. Understanding the pathology of schizophrenia: recent advances from the study of the molecular architecture of postmortem CNS tissue.

Authors: B Dean
Journal: Postgrad Med J Date: 2002-03 Impact factor: 2.401

Review 2. Animal models of schizophrenia: a critical review.

Authors: E R Marcotte; D M Pearson; L K Srivastava
Journal: J Psychiatry Neurosci Date: 2001-11 Impact factor: 6.186

3. Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia.

Authors: Surendra P Singh; Vidhi Singh
Journal: CNS Drugs Date: 2011-10-01 Impact factor: 5.749

Review 4. GABAergic interneuron origin of schizophrenia pathophysiology.

Authors: Kazu Nakazawa; Veronika Zsiros; Zhihong Jiang; Kazuhito Nakao; Stefan Kolata; Shuqin Zhang; Juan E Belforte
Journal: Neuropharmacology Date: 2011-01-26 Impact factor: 5.250

5. Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats.

Authors: D C Hoffman
Journal: J Neural Transm Gen Sect Date: 1992

Review 6. Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.

Authors: William R Perlman; Cynthia Shannon Weickert; Mayada Akil; Joel E Kleinman
Journal: J Psychiatry Neurosci Date: 2004-07 Impact factor: 6.186

Review 7. Recent advances in targeting the ionotropic glutamate receptors in treating schizophrenia.

Authors: Robert E McCullumsmith; John Hammond; Adam Funk; James H Meador-Woodruff
Journal: Curr Pharm Biotechnol Date: 2012-06 Impact factor: 2.837

8. Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission.

Authors: Kent Jardemark; Monica M Marcus; Anna Malmerfelt; Mohammed Shahid; Torgny H Svensson
Journal: Psychopharmacology (Berl) Date: 2011-11-09 Impact factor: 4.530

9. The NMDA positive modulator D-cycloserine potentiates the neuroleptic activity of D1 and D2 dopamine receptor blockers in the rat.

Authors: R Dall'Olio; O Gandolfi
Journal: Psychopharmacology (Berl) Date: 1993 Impact factor: 4.530

10. Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: milacemide.

Authors: J Semba; G Curzon; P N Patsalos
Journal: Br J Pharmacol Date: 1993-04 Impact factor: 8.739